RCKT
Rocket Pharmaceuticals Inc

3,822
Mkt Cap
$508.1M
Volume
4.11M
52W High
$8.26
52W Low
$2.19
PE Ratio
-2.33
RCKT Fundamentals
Price
$4.95
Prev Close
$4.68
Open
$4.69
50D MA
$4.03
Beta
1.12
Avg. Volume
2.44M
EPS (Annual)
-$2.01
P/B
1.83
Rev/Employee
$0.00
$225.99
Loading...
Loading...
News
all
press releases
Rocket Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:RCKT)
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) saw unusually large options trading activity on Thursday. Stock investors purchased 7,425 call options on the stock. This represents an increase of 529% compared to the typical volume of 1,181 call options...
MarketBeat·1h ago
News Placeholder
More News
News Placeholder
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Up 9.3% - Should You Buy?
Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 9.3% - Here's What Happened...
MarketBeat·20h ago
News Placeholder
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Hold" by Brokerages
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) have received an average recommendation of "Hold" from the eighteen analysts that are presently covering the firm, Marketbeat...
MarketBeat·2d ago
News Placeholder
Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 4.4% - Here's What Happened
Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 4.4% - Time to Sell...
MarketBeat·9d ago
News Placeholder
Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 4.8% - Should You Sell?
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 4.8% - Here's Why...
MarketBeat·15d ago
News Placeholder
Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 5.4% - What's Next?
Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 5.4% - Time to Buy...
MarketBeat·17d ago
News Placeholder
Rocket Pharmaceuticals (NASDAQ:RCKT) Cut to Sell at Wall Street Zen
Wall Street Zen downgraded Rocket Pharmaceuticals from a "hold" rating to a "sell" rating in a research note on Sunday...
MarketBeat·18d ago
News Placeholder
The Goldman Sachs Group Forecasts Strong Price Appreciation for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock
The Goldman Sachs Group lifted their price target on shares of Rocket Pharmaceuticals from $2.00 to $3.00 and gave the stock a "sell" rating in a research note on Monday...
MarketBeat·24d ago
News Placeholder
Brokers Set Expectations for RCKT FY2026 Earnings
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Analysts at Lifesci Capital issued their FY2026 earnings estimates for shares of Rocket Pharmaceuticals in a report released on Thursday...
MarketBeat·24d ago
News Placeholder
Lifesci Capital Upgrades Rocket Pharmaceuticals (NASDAQ:RCKT) to Strong-Buy
Lifesci Capital upgraded Rocket Pharmaceuticals to a "strong-buy" rating in a research report on Thursday...
MarketBeat·26d ago
<
1
2
...
>

Latest RCKT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.